Blood Test to Predict Radiation Response and Toxicity in Patients Undergoing Radiation Therapy
Sponsor: DxTerity Diagnostics
This observational or N/A phase trial investigates Radiation Therapy and is currently ongoing. DxTerity Diagnostics leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
-
Mar 2019 — Jan 2021 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Jun 2018 — Mar 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2017 — Sep 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- DxTerity Diagnostics
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .